Nvidia(US:NVDA) BOCOM International·2025-11-24 02:20Group 1: Nvidia (NVDA US) - The company's performance and guidance exceeded expectations, with FY3Q26 revenue of $57 billion and EPS of $1.30, both surpassing market expectations [1] - Management's guidance for FY4Q26 revenue is $65 billion (+/-2%), significantly above market expectations, with a gross margin forecast of 75% [2] - The short-term guidance is positive, but investors remain focused on the sustainability of demand in CY26 and beyond, particularly in the AI sector [2] Group 2: CSPC Pharmaceutical Group (1093 HK) - The company's 3Q25 performance showed a slight recovery, with revenue of 6.62 billion HKD, although it was slightly below expectations [3] - The oncology segment continues to be affected by centralized procurement, but the decline has narrowed [3] - Management expects a return to positive growth in 2026, with significant R&D investments planned [3][4] Group 3: Link REIT (823 HK) - The company reported a 1.8% year-on-year decline in revenue for the first half of FY25/26, primarily due to retail market fluctuations [7] - The rental adjustment rate for renewals in Hong Kong and mainland China was negative, impacting property income [8] - Despite challenges, the company maintains a buy rating, believing that recent stock price corrections present buying opportunities [8]